US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Qudian Inc.

2.47

-0.0500-1.98%

Post-market: 2.470.00000.00%17:19 EDT

Volume:965.74K

Turnover:2.39M

Market Cap:467.83M

PE:92.11

High:2.53

Open:2.50

Low:2.41

Close:2.52

Loading ...

Overview Company News Filings

February 2025's Top US Penny Stocks To Watch

Simply Wall St.

Arcus Biosciences Retains Rights to Casdatifan, a Potential Best-in-Class HIF-2a Inhibitor, and Announces Pricing of $150 Million Common Stock Offering

New Data Demonstrated Best-in-Class Potential for Casdatifan, a HIF-2a Inhibitor, in Patients with Metastatic Kidney Cancer

QD Laser, Inc. Reports Mixed Financial Results Amid Sales Growth

QD Laser 9-Mos Parent Loss Y328.00M Vs Loss Y369.00M

Third Harmonic Bio Announces Phase 1 Clinical Results for THB335 and Provides Corporate Strategic Update

Arcus Biosciences to Present New Data from Casdatifan, a HIF-2a Inhibitor, in an Oral Presentation at the 2025 ASCO GU Symposium

Pfizer Reports Strong Full-Year 2024 Results And Reaffirms 2025 Guidance

Stock Track | Qudian Inc. Plummets 5.05% as Auditor Change Raises Concerns Over Financial Reporting

Qudian Inc. Announces Appointment of Auditor

THOMSON REUTERS

Qudian Inc. Announces Appointment of Auditor

3 Promising Penny Stocks On US Exchanges In January 2025

Simply Wall St.

C4 Therapeutics Announces 2025 Milestones Across Clinical Portfolio of Degrader Medicines Pursuing Targets of High Unmet Need in Oncology

Tyra Biosciences Receives IND Clearance from FDA to Proceed with Phase 2 Study of TYRA-300 in Non-Muscle Invasive Bladder Cancer (SURF302)

Samsung Display to Unveil QD-OLED Panels at CES 2025

MT Newswires Live

MicroCloud Hologram Inc. Develops Semiconductor Quantum Dot Hole Spin Qubit Technology, Advancing the Frontiers of Quantum Computing

Asian Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading

MT Newswires Live

Aadi Bioscience Leads 3 Promising US Penny Stocks

Simply Wall St.

InflaRx Announces First Patient Dosed in Phase 2a Study for Oral C5aR Inhibitor INF904

Rigel Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th ASH Annual Meeting and Exposition

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/QD/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"QD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"QD\",,,,,undefined,":{"symbol":"QD","market":"US","secType":"STK","nameCN":"Qudian Inc.","latestPrice":2.47,"timestamp":1745265600000,"preClose":2.52,"halted":0,"volume":965744,"hourTrading":{"tag":"盘后","latestPrice":2.47,"preClose":2.47,"latestTime":"17:19 EDT","volume":580417,"amount":1433629.99,"timestamp":1745270347914},"delay":0,"floatShares":121052982,"shares":189403851,"eps":0.026816,"marketStatus":"Not Yet Opened","change":-0.05,"latestTime":"04-21 16:00:00 EDT","open":2.5,"high":2.53,"low":2.41,"amount":2389556.6036992,"amplitude":0.047619,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.026816,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745308800000},"marketStatusCode":0,"adr":1,"adrRate":1,"listingDate":1508299200000,"exchange":"NYSE","adjPreClose":2.52,"preHourTrading":{"tag":"盘前","latestPrice":2.49,"preClose":2.52,"latestTime":"08:37 EDT","volume":3,"amount":7.470000000000001,"timestamp":1745239066930},"postHourTrading":{"tag":"盘后","latestPrice":2.47,"preClose":2.47,"latestTime":"17:19 EDT","volume":580417,"amount":1433629.99,"timestamp":1745270347914},"volumeRatio":1.561115,"impliedVol":0.9848,"impliedVolPercentile":0.816},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"QD\",,,,,undefined,":{"symbol":"QD","floatShares":121052982,"roa":"-1.34%","roe":"0.35%","lyrEps":0.025399,"volumeRatio":1.561115,"shares":189403851,"dividePrice":0,"high":2.53,"amplitude":0.047619,"preClose":2.52,"low":2.41,"week52Low":1.52,"pbRate":"0.30","psRate":"15.00","week52High":3.34,"institutionHeld":0,"latestPrice":2.47,"eps":0.026816,"divideRate":0,"volume":965744,"delay":0,"ttmEps":0.026816,"open":2.5,"prevYearClose":2.82,"prevWeekClose":2.52,"prevMonthClose":2.69,"prevQuarterClose":2.69,"fiveDayClose":2.37,"twentyDayClose":2.84,"sixtyDayClose":2.93},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"QD\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2512111049","title":"February 2025's Top US Penny Stocks To Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2512111049","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512111049?lang=en_us&edition=fundamental","pubTime":"2025-02-19 08:11","pubTimestamp":1739923865,"startTime":"0","endTime":"0","summary":"As of February 2025, the U.S. stock market is experiencing a notable upswing, with the S&P 500 reaching record highs and major indices showing positive momentum. In this context, penny stocks—often seen as investments in smaller or newer companies—remain a relevant area for potential growth opportunities. While the term \"penny stocks\" might seem outdated, these investments can still offer significant returns when backed by strong financial health and strategic positioning. Let's explore several penny stocks that could pair balance sheet strength with long-term potential.Overview: Dingdong  Limited is an e-commerce company operating in China, with a market capitalization of approximately $754.10 million.Take a closer look at Dingdong 's potential here in our financial health report.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/february-2025s-top-us-penny-001105463.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SRG","BK4166","BK4563","BK4213","BK4021","PHX","BK4113","DDL","BK4233","BABB","REIT","BK4205","QD","BK4551","SB","PVL","BK4080","BK4209","BK4539","BK4503"],"gpt_icon":0},{"id":"2512159344","title":"Arcus Biosciences Retains Rights to Casdatifan, a Potential Best-in-Class HIF-2a Inhibitor, and Announces Pricing of $150 Million Common Stock Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2512159344","media":"Business Wire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512159344?lang=en_us&edition=fundamental","pubTime":"2025-02-18 19:57","pubTimestamp":1739879820,"startTime":"0","endTime":"0","summary":"Gilead Sciences’ window to exercise its option to casdatifan has expired; $150 million financing enables Arcus to independently advance its development program for casdatifan. New data from the ARC-20 study in patients with clear cell renal cell carcinoma  showed that casdatifan monotherapy demonstrated improvements in the rate of primary progression, overall response rate  and progression-free survival  and reinforced its differentiation relative to published data from studies with HIF-2a inhibitors to date. Arcus will host a conference call today to discuss the ARC-20 results and casdatifan development plans at 5:00 AM PT / 8:00 AM ET. The new data from ARC-20, a Phase 1/1b study of the HIF-2a inhibitor casdatifan in ccRCC, were presented in a rapid oral session at the 2025 American Society of Clinical Oncology  Genitourinary  Cancers Symposium by Dr. Toni Choueiri, Dana-Farber Cancer Institute. The presentation included ORR for the 50mg twice-daily  cohort, 50mg o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/arcus-biosciences-retains-rights-casdatifan-115700300.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4563","PFS","BK4179","ORR","BK4503","RCUS","BK4139","BK4166","QD","IO","BK4211","BK4195"],"gpt_icon":0},{"id":"2511860458","title":"New Data Demonstrated Best-in-Class Potential for Casdatifan, a HIF-2a Inhibitor, in Patients with Metastatic Kidney Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2511860458","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511860458?lang=en_us&edition=fundamental","pubTime":"2025-02-16 04:45","pubTimestamp":1739652300,"startTime":"0","endTime":"0","summary":"A 9.7-month median progression-free survival  was reached for the 50mg twice-daily  casdatifan monotherapy cohort of the Phase 1/1b ARC-20 study; mPFS was not yet reached for other cohorts. Across all three monotherapy cohorts presented, casdatifan demonstrated improvements in the rate of primary progression, overall response rate  and progression-free survival  relative to published data from studies with HIF-2a inhibitors to date. Arcus will host a conference call to discuss these data at 5:00 AM PT / 8:00 AM ET on Tuesday, February 18, 2025. \"The newest data are from the 100mg cohort using the tablet formulation and the expected go-forward dose for pivotal studies, which showed a 33% confirmed response rate despite the relatively short follow-up,\" said Richard Markus, M.D., Ph.D., chief medical officer at Arcus Biosciences. \"Casdatifan continues to be well tolerated, with a very low discontinuation rate, supporting its strong potential in combination therapy. We look forward to shar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/data-demonstrated-best-class-potential-204500902.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4211","BK4195","BK4166","PFS","QD","BK4503","BK4563","RCUS","IO","BK4139","ORR","BK4179"],"gpt_icon":0},{"id":"2511518079","title":"QD Laser, Inc. Reports Mixed Financial Results Amid Sales Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2511518079","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511518079?lang=en_us&edition=fundamental","pubTime":"2025-02-13 16:20","pubTimestamp":1739434817,"startTime":"0","endTime":"0","summary":"QD Laser, Inc. ( ($JP:6613) ) has shared an update. QD Laser, Inc. reported its financial results for the nine months ending December 31, 2024, sho...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/qd-laser-inc-reports-mixed-financial-results-amid-sales-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/qd-laser-inc-reports-mixed-financial-results-amid-sales-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QD"],"gpt_icon":0},{"id":"2511934597","title":"QD Laser 9-Mos Parent Loss Y328.00M Vs Loss Y369.00M","url":"https://stock-news.laohu8.com/highlight/detail?id=2511934597","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511934597?lang=en_us&edition=fundamental","pubTime":"2025-02-13 15:30","pubTimestamp":1739431800,"startTime":"0","endTime":"0","summary":"QD Laser Inc.  Japan Nine Months Ended December 31 PARENT20242023 RevenueY925.00 mlnY904.00 mln Operating Profit Pretax Profit Net Profit Per share Earnings Dividend First quarterN/AN/A MidyearY0.00Y0.00 Third quarterN/AN/A Year-endY0.00Y0.00 AnnualY0.00Y0.00 Figures in parentheses are losses. Results are based on Japanese accounting standards. Dividends for periods in the future are forecasts.This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4503","BK4563","QD","BK4166"],"gpt_icon":0},{"id":"2510800545","title":"Third Harmonic Bio Announces Phase 1 Clinical Results for THB335 and Provides Corporate Strategic Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2510800545","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510800545?lang=en_us&edition=fundamental","pubTime":"2025-02-11 20:00","pubTimestamp":1739275200,"startTime":"0","endTime":"0","summary":"THB335 Phase 1 data support advancement into Phase 2 clinical trial inchronic spontaneous urticaria (CSU) Company initiating process to leverage balance sheet strength tomaximize shareholder value  Ca","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/11/3024041/0/en/Third-Harmonic-Bio-Announces-Phase-1-Clinical-Results-for-THB335-and-Provides-Corporate-Strategic-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4503","BK4020","BK4563","HLIT","BK4166","QD"],"gpt_icon":0},{"id":"2510815670","title":"Arcus Biosciences to Present New Data from Casdatifan, a HIF-2a Inhibitor, in an Oral Presentation at the 2025 ASCO GU Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2510815670","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510815670?lang=en_us&edition=fundamental","pubTime":"2025-02-11 06:00","pubTimestamp":1739224800,"startTime":"0","endTime":"0","summary":"New data from ARC-20, a Phase 1/1b study of the HIF-2a inhibitor casdatifan in clear cell renal cell carcinoma , will be presented in a rapid oral session by Dr. Toni Choueiri, Dana-Farber Cancer Institute. The presentation will include initial data from the 100mg once-daily  tablet cohort and updated data for the 50mg twice-daily  and 50mg QD cohorts. Arcus will host a conference call to discuss the ARC-20 data at 5:00 AM PT / 8:00 AM ET on Tuesday, February 18, 2025. The oral presentation will highlight safety and efficacy data from three cohorts of ARC-20, which evaluated casdatifan monotherapy in patients that had received both prior TKI and anti-PD-1 therapy. The presentation will include initial data for the 100mg QD tablet cohort, our selected dose and formulation for Arcus’s Phase 3 studies, as well as updated data for the 50mg BID and 50mg QD expansion cohorts of ARC-20.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/arcus-biosciences-present-data-casdatifan-220000222.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4503","RCUS","BK4563","QD","BK4166","BK4139"],"gpt_icon":0},{"id":"2508345850","title":"Pfizer Reports Strong Full-Year 2024 Results And Reaffirms 2025 Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2508345850","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508345850?lang=en_us&edition=fundamental","pubTime":"2025-02-04 19:45","pubTimestamp":1738669500,"startTime":"0","endTime":"0","summary":"Full-Year 2024 Revenues of $63.6 Billion, Reflecting 7% Year-over-Year Operational Growth. Excluding Contributions from Paxlovid and Comirnaty, Revenues Grew 12% Operationally. Full-Year 2024 Reported Diluted EPS of $1.41 and Adjusted Diluted EPS of $3.11. Fourth-Quarter 2024 Revenues of $17.8 Billion, Reflecting 21% Year-over-Year Operational Growth. Fourth-Quarter 2024 Reported Diluted EPS of $0.07 and Adjusted Diluted EPS of $0.63. On Track to Deliver Overall Net Cost Savings of Approximately $4.5 Billion by End of 2025 from Ongoing Cost Realignment Program. Reaffirms All Components of Full-Year 2025 Financial Guidance, including Revenues in a Range of $61.0 to $64.0 Billion and Adjusted Diluted EPS in a Range of $2.80 to $3.00. NEW YORK, February 04, 2025----Pfizer Inc.  reported financial results for fourth-quarter and full-year 2024 and reaffirmed its 2025 financial guidance provided on December 17, 2024.The fourth-quarter 2024 earnings presentation and accompanying prepared rema","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"e75b2b7dcb07c669b5aa92e4e319edbe","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pfizer-reports-strong-full-2024-114500880.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0225284248.USD","LU0306806265.USD","IE00BBT3K403.USD","SGXZ57979304.SGD","EC","BCG","LU1883839398.USD","LU0289739699.SGD","LU0234572021.USD","BK4568","SG9999002232.USD","BK4135","LU0306807586.USD","IE00BLSP4239.USD","BK4588","BK4201","PFE","BK4592","SG9999001176.SGD","BK4211","BK4551","BK4166","OS","MBC","LU1894683348.USD","LU0170899867.USD","BK4599","BK4503","BK4533","QD","BK4097","IE00B19Z3B42.SGD","LU0122379950.USD","SG9999001176.USD","SG9999002224.SGD","ORR","BNTX","BK4139","LU0058720904.USD","BK4195","LU0225771236.USD","BK4535","IE00BLSP4452.SGD","LU0868494617.USD","LU1066051498.USD","BK4548","PFS","LU0321505868.SGD","BK4581"],"gpt_icon":0},{"id":"1177892181","title":"Stock Track | Qudian Inc. Plummets 5.05% as Auditor Change Raises Concerns Over Financial Reporting","url":"https://stock-news.laohu8.com/highlight/detail?id=1177892181","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177892181?lang=en_us&edition=fundamental","pubTime":"2025-02-01 04:56","pubTimestamp":1738356986,"startTime":"0","endTime":"0","summary":"Qudian Inc. , a consumer-oriented technology company, saw its stock price plummet 5.05% in the intraday session on Friday. The decline came after the company announced the appointment of Marcum Asia CPAs LLP as its new independent registered public accounting firm.While auditor changes are not uncommon for companies, Qudian's announcement highlighted some potential concerns regarding its financial reporting and auditing processes. The company had initially appointed BDO China Shu Lun Pan Certifi","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Stock Track | Qudian Inc. Plummets 5.05% as Auditor Change Raises Concerns Over Financial Reporting","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["QD"],"gpt_icon":0},{"id":"2507953667","title":"Qudian Inc. Announces Appointment of Auditor","url":"https://stock-news.laohu8.com/highlight/detail?id=2507953667","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507953667?lang=en_us&edition=fundamental","pubTime":"2025-01-31 18:17","pubTimestamp":1738318669,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250131:nTUA7CVQLR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["QD","BK4166","BK4503","BK4563"],"gpt_icon":0},{"id":"2507953125","title":"Qudian Inc. Announces Appointment of Auditor","url":"https://stock-news.laohu8.com/highlight/detail?id=2507953125","media":"PR Newswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507953125?lang=en_us&edition=fundamental","pubTime":"2025-01-31 18:00","pubTimestamp":1738317600,"startTime":"0","endTime":"0","summary":"XIAMEN, China, Jan. 31, 2025 /PRNewswire/ -- Qudian Inc.  , a consumer-oriented technology company, today announced the appointment of Marcum Asia CPAs LLP  as the Company's new independent registered public accounting firm.The Company previously announced the appointment of BDO China Shu Lun Pan Certified Public Accountants LLP  as its independent registered public accounting firm on September 6, 2024. After the announcement, BDO informed the Company's management and audit committee that, due to constraints on its internal resources, BDO may not be able to complete its audit work according to the timetable proposed by the Company. After further discussions, the Company decided to revoke BDO's appointment and BDO accepted the revocation. The revocation of BDO's appointment was not as a result of any disagreement between the Company and BDO on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedures.After carefully considering add","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/qudian-inc-announces-appointment-auditor-100000240.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/qudian-inc-announces-appointment-auditor-100000240.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4166","BK4503","BK4563","QD"],"gpt_icon":0},{"id":"2505250427","title":"3 Promising Penny Stocks On US Exchanges In January 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2505250427","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505250427?lang=en_us&edition=fundamental","pubTime":"2025-01-21 08:06","pubTimestamp":1737417995,"startTime":"0","endTime":"0","summary":"As of January 2025, the U.S. stock market is experiencing a surge, with major indices like the S&P 500 and Dow Jones Industrial Average posting their best weekly gains in two months, driven by a rally in big-tech stocks. For investors looking beyond established giants, penny stocks—often representing smaller or newer companies—continue to hold potential despite being considered an outdated term. These stocks can offer affordability and growth potential when paired with strong financials; here we explore three penny stocks that stand out for their financial strength and resilience.GSI Technology, Inc. faces challenges typical of penny stocks, with increasing losses over the past five years and a negative return on equity. The company is unprofitable and has less than a year of cash runway, although its short-term assets exceed both short- and long-term liabilities. Despite high volatility in its share price, GSI's recent selection by the U.S. Army for an SBIR contract highlights potenti","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-promising-penny-stocks-us-000635303.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BABB","BK4166","QD","BK4551","BK4539","BK4503","GSIT","BK4021","SB","BK4209","DDL","BK4113","BK4563"],"gpt_icon":0},{"id":"2503546521","title":"C4 Therapeutics Announces 2025 Milestones Across Clinical Portfolio of Degrader Medicines Pursuing Targets of High Unmet Need in Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2503546521","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503546521?lang=en_us&edition=fundamental","pubTime":"2025-01-14 20:00","pubTimestamp":1736856000,"startTime":"0","endTime":"0","summary":"Cemsidomide Data Presented at American Society of Hematology (ASH) Annual Meeting Support Best-in-Class Profile; Program Advancing to Next Phase of Clinical Development in Multiple Myeloma and Non-Hod","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/14/3009167/0/en/C4-Therapeutics-Announces-2025-Milestones-Across-Clinical-Portfolio-of-Degrader-Medicines-Pursuing-Targets-of-High-Unmet-Need-in-Oncology.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","LU2463526074.USD","BK4166","BK4139","CRC","BK4109","BK4503","ASH","BK4563","BK4213","MDCO","CCCC","QD","LU0456854461.SGD","LU0266512127.USD"],"gpt_icon":0},{"id":"2502461865","title":"Tyra Biosciences Receives IND Clearance from FDA to Proceed with Phase 2 Study of TYRA-300 in Non-Muscle Invasive Bladder Cancer (SURF302)","url":"https://stock-news.laohu8.com/highlight/detail?id=2502461865","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502461865?lang=en_us&edition=fundamental","pubTime":"2025-01-10 21:00","pubTimestamp":1736514000,"startTime":"0","endTime":"0","summary":"-TYRA appoints urologic oncologist, Erik Goluboff, M.D., as SVP, Clinical Development to lead NMIBC-. -First patient expected to be dosed in SURF302 in Q2 2025-. CARLSBAD, Calif., Jan. 10, 2025 /PRNewswire/ -- Tyra Biosciences, Inc. , a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor  biology, announced today that the U.S. Food and Drug Administration  cleared its Investigational New Drug  application for TYRA-300 allowing the company to proceed with a Phase 2 clinical trial of TYRA-300 in low-grade, intermediate risk non-muscle invasive bladder cancer . This program will be led by newly appointed Dr. Erik Goluboff, SVP, Clinical Development of TYRA, who brings more than thirty years of experience as an academic urologic oncologist, principal investigator, practicing urologist and most recently Principal Medical Lead for GU/GI cancers at Genentech/Roche.Dr. Goluboff joins","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/tyra-biosciences-receives-ind-clearance-130000689.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tyra-biosciences-receives-ind-clearance-130000689.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PFS","BK4161","BK4195","QD","BK4153","BK4211","BK4166","TYRA","ACH","CR","BK4139","BK4563","BK4503"],"gpt_icon":0},{"id":"2501279632","title":"Samsung Display to Unveil QD-OLED Panels at CES 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2501279632","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501279632?lang=en_us&edition=fundamental","pubTime":"2025-01-07 18:44","pubTimestamp":1736246642,"startTime":"0","endTime":"0","summary":"Samsung Electronics  subsidiary Samsung Display will debut two QD-OLED products--a 27-inch UHD gaming monitor with a 240Hz refresh rate and a 27-inch QHD model with 500Hz refresh rate--at the CES 2025, the company said Monday.The new ultra-high definition  panel boasts a pixel density of 160 pixels per inch , surpassing the 140 PPI of the existing 31.5-inch model for more detailed, and sharper visuals, the release said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["QD","BK4573","BK4585","BK4518","OLED","PPI","BK4563","BK4166","BK4141","BK4570","BK4503"],"gpt_icon":0},{"id":"2495540541","title":"MicroCloud Hologram Inc. Develops Semiconductor Quantum Dot Hole Spin Qubit Technology, Advancing the Frontiers of Quantum Computing","url":"https://stock-news.laohu8.com/highlight/detail?id=2495540541","media":"PR Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495540541?lang=en_us&edition=fundamental","pubTime":"2024-12-30 22:00","pubTimestamp":1735567200,"startTime":"0","endTime":"0","summary":"SHENZHEN, China, Dec. 30, 2024 /PRNewswire/ -- MicroCloud Hologram Inc. , , based on their in-depth research and continuous innovation in quantum technology, they have pioneered an advanced technological solution: using a fast adiabatic driving protocol to achieve coherent control of two heavy hole spin qubits in a double quantum dot  system. In traditional quantum experimental protocols, conventional methods such as linear ramps, π-pulses, or Landau-Zener channels have contributed to the incremental development of quantum control techniques. However, due to their inherent physical limitations, these methods struggle to meet the current stringent demands for high fidelity in quantum information processing. In contrast, the fast adiabatic driving protocol developed by HOLO demonstrates significant technological advantages.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/microcloud-hologram-inc-develops-semiconductor-140000986.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/microcloud-hologram-inc-develops-semiconductor-140000986.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HOLOW","BK4023","QD","BK4503","BK4166","HOLO","BK4563"],"gpt_icon":1},{"id":"2493276423","title":"Asian Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2493276423","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493276423?lang=en_us&edition=fundamental","pubTime":"2024-12-23 23:41","pubTimestamp":1734968497,"startTime":"0","endTime":"0","summary":"Asian equities traded in the US as American depositary receipts kicked off the holiday-shortened week on a positive note Monday morning, rising 1.04% to 2,062.40 on the S&P Asia 50 ADR Index.From North Asia, the gainers were led by automotive company Honda Motor  and solar project developer Emeren Group , which climbed 13% and 6.6% respectively. They were followed by consumer lending firm Qudian  and fintech platform Jiayin Group , which rose 4.1% and 3.8% respectively.The decliners from North Asia were led by computer hardware maker Canaan  and brand platform 36Kr , which fell 8.4% and 7.1% respectively. They were followed by mobile big data platform Aurora Mobile  and healthcare platform 111 , which dropped 6.8% and 4.5% respectively.From South Asia, the gainers were led by telecommunications operator Telekomunikasi Indonesia , which rose 2.2%, followed by financial services company HDFC Bank  and pharmaceutical company Dr. Reddy's Laboratories , which were up 0.5% and 0.1% respectiv","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4085","IE00B3M56506.USD","SOL","BK7502","JG","BK4563","LU0898667661.SGD","AFG","BK7062","LU0210637038.USD","SE","BK4207","BK4099","HMC.AU","RDY","IE0034224299.USD","LU0791590937.USD","SG9999014021.USD","CAN.AU","SOL.AU","CAN","LU0348816934.USD","INFY","BK4532","LU1242518931.SGD","TLK","LU1282648689.USD","LU2045819591.USD","YI","IE00BYTNYM70.SGD","LU0261945553.USD","QD","BK4115","BK4588","BK4551","KRKR","BK4581","LU0831103253.SGD","LU1804176565.USD","HMC","JFIN","LU0630378429.USD","SG9999014013.SGD","HDB","RDY.AU","BK4526","SIFY","WIT","BK4566"],"gpt_icon":1},{"id":"2493279179","title":"Aadi Bioscience Leads 3 Promising US Penny Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2493279179","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493279179?lang=en_us&edition=fundamental","pubTime":"2024-12-23 08:09","pubTimestamp":1734912591,"startTime":"0","endTime":"0","summary":"As the U.S. stock market navigates a challenging week marked by encouraging inflation data yet overall losses, investors are exploring diverse opportunities to mitigate risk and capitalize on potential gains. Penny stocks, often associated with smaller or newer companies, continue to attract attention due to their potential for significant returns when backed by strong financial health. Despite being considered a niche area of investment today, these stocks can offer intriguing opportunities for those willing to explore beyond traditional large-cap options.Overview: Aadi Bioscience, Inc. is a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes, with a market cap of $83.55 million.Get an in-depth perspective on Aadi Bioscience's performance by reading our balance sheet health report here.Understand Aadi Bioscience's earnings outlook by examining our growth report.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/NPWPwaqd_YNMPuUbekamwQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/17286ad821a1799fbe520d67c5c5f1ea","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/NPWPwaqd_YNMPuUbekamwQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/17286ad821a1799fbe520d67c5c5f1ea"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aadi-bioscience-leads-3-promising-000951326.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4209","BABB","BK4563","QD","BK4139","BK4539","IMRX","AADI","BK4166","SB","BK4021","BK4503"],"gpt_icon":0},{"id":"2492175744","title":"InflaRx Announces First Patient Dosed in Phase 2a Study for Oral C5aR Inhibitor INF904","url":"https://stock-news.laohu8.com/highlight/detail?id=2492175744","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492175744?lang=en_us&edition=fundamental","pubTime":"2024-12-20 20:30","pubTimestamp":1734697800,"startTime":"0","endTime":"0","summary":"JENA,Germany, Dec.  20, 2024  (GLOBE NEWSWIRE) -- InflaRxN.V.(Nasdaq:IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/20/3000513/0/en/InflaRx-Announces-First-Patient-Dosed-in-Phase-2a-Study-for-Oral-C5aR-Inhibitor-INF904.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","BK4218","USA","BK4563","PRO","BK4166","BK4181","PK","BK4503","QD"],"gpt_icon":0},{"id":"2490033037","title":"Rigel Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th ASH Annual Meeting and Exposition","url":"https://stock-news.laohu8.com/highlight/detail?id=2490033037","media":"PR Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490033037?lang=en_us&edition=fundamental","pubTime":"2024-12-10 01:02","pubTimestamp":1733763720,"startTime":"0","endTime":"0","summary":"R289 was generally well tolerated and demonstrated signs of preliminary clinical activity in elderly heavily pretreated LR-MDS patients. SOUTH SAN FRANCISCO, Calif., Dec. 9, 2024 /PRNewswire/ -- Rigel Pharmaceuticals, Inc., a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced initialdata from its ongoing Phase 1b study evaluating R2891, an oral prodrug of R835, a potent and selective dual inhibitor of IRAK1 and IRAK4, in patients with relapsed or refractory (R/R) lower-risk myelodysplastic syndrome . The data is beingpresented today by Dr. Guillermo Garcia-Manero  at the 66th American Society of Hematology  Annual Meeting and Exposition being held December 7-10, in San Diego, California and virtually.Rigel's open-label, Phase 1b study of R289 is enrolling patients with lower-risk MDS who are R/R to prior therapies . The primary objective of the study is to assess the safety and tolerability of R289 with secondary objectives to assess pre","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/y.2KhNmww8BW2625tcZbsw--~B/aD0yMTY7dz0zNjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/6d5d4ea80b797a53937d37e2b5610bea","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/y.2KhNmww8BW2625tcZbsw--~B/aD0yMTY7dz0zNjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/6d5d4ea80b797a53937d37e2b5610bea"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/rigel-highlights-initial-data-ongoing-170200978.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/rigel-highlights-initial-data-ongoing-170200978.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BLDYK493.USD","ALT","BK4109","LU2065731478.USD","BK4161","BK4563","BK4139","LU2463526074.USD","ASH","BK4599","IE00B64QTZ34.USD","BK4503","RIGL","AST","LU1878469433.USD","BK4166","RBC","QD"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":68,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/QD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-20","symbol":"QD","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742443200000,"reportTimeType":"pre","actualEps":-0.05},{"market":"US","date":"2024-11-22","symbol":"QD","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1732251600000,"reportTimeType":"pre","actualEps":0.1},{"market":"US","date":"2024-09-06","symbol":"QD","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1725595200000,"reportTimeType":"pre","actualEps":0.07},{"market":"US","date":"2024-06-13","symbol":"QD","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1718251200000,"reportTimeType":"pre","actualEps":-0.05},{"market":"US","date":"2024-03-18","symbol":"QD","fiscalQuarterEnding":"2023/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1710734400000,"reportTimeType":"pre","actualEps":-0.08}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"QD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"QD\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/QD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"QD","date":"2025-04-17","current":82.909148,"percent":0.89781,"low":-88.607914,"twenty":-4.501898,"median":1.979101,"eighty":16.305595,"high":110.235059,"avg":10.931498,"sd":34.396961,"marketCap":465933473},"quantilePoints":[{"date":"2020-04-24","current":0.890791,"twenty":3.206684,"median":4.955908,"eighty":9.830591,"marketCap":410602488},{"date":"2020-05-01","current":0.878138,"twenty":2.284286,"median":4.944031,"eighty":9.808673,"marketCap":405950457},{"date":"2020-05-08","current":0.962192,"twenty":2.215217,"median":4.934765,"eighty":9.770965,"marketCap":444008313},{"date":"2020-05-15","current":0.910759,"twenty":2.195189,"median":4.927236,"eighty":9.748922,"marketCap":418636409},{"date":"2020-05-22","current":0.831163,"twenty":2.178041,"median":4.907052,"eighty":9.736972,"marketCap":380578554},{"date":"2020-05-29","current":1.485647,"twenty":2.15827,"median":4.857685,"eighty":9.731582,"marketCap":380578554},{"date":"2020-06-05","current":1.513828,"twenty":2.111924,"median":4.836038,"eighty":9.713673,"marketCap":390727315},{"date":"2020-06-12","current":1.494313,"twenty":2.077217,"median":4.820821,"eighty":9.690916,"marketCap":385652934},{"date":"2020-06-19","current":1.697674,"twenty":2.054702,"median":4.802938,"eighty":9.676676,"marketCap":438933932},{"date":"2020-06-26","current":1.709075,"twenty":1.997591,"median":4.760441,"eighty":9.653813,"marketCap":441471122},{"date":"2020-07-02","current":1.68657,"twenty":1.963896,"median":4.75815,"eighty":9.642907,"marketCap":436396741},{"date":"2020-07-10","current":2.312239,"twenty":1.963896,"median":4.748623,"eighty":9.604742,"marketCap":603851305},{"date":"2020-07-17","current":1.97954,"twenty":1.963896,"median":4.718462,"eighty":9.559259,"marketCap":517586833},{"date":"2020-07-24","current":1.616747,"twenty":1.918817,"median":4.713887,"eighty":9.538168,"marketCap":421173599},{"date":"2020-07-31","current":1.568191,"twenty":1.76894,"median":4.700634,"eighty":9.522584,"marketCap":411024838},{"date":"2020-08-07","current":1.614876,"twenty":1.736998,"median":4.673639,"eighty":9.493529,"marketCap":423710790},{"date":"2020-08-14","current":1.755578,"twenty":1.705998,"median":4.644245,"eighty":9.483072,"marketCap":461768645},{"date":"2020-08-21","current":1.622789,"twenty":1.673427,"median":4.641146,"eighty":9.471666,"marketCap":428785170},{"date":"2020-08-28","current":1.591166,"twenty":1.651695,"median":4.639855,"eighty":9.458685,"marketCap":423710790},{"date":"2020-09-04","current":1.471861,"twenty":1.642989,"median":4.637355,"eighty":9.446127,"marketCap":393264505},{"date":"2020-09-11","current":2.9708,"twenty":1.644704,"median":4.630228,"eighty":9.441013,"marketCap":375519436},{"date":"2020-09-18","current":2.763282,"twenty":1.645206,"median":4.617694,"eighty":9.438537,"marketCap":352683795},{"date":"2020-09-25","current":2.544944,"twenty":1.64953,"median":4.600475,"eighty":9.427936,"marketCap":322236273},{"date":"2020-10-02","current":2.612554,"twenty":1.651477,"median":4.596099,"eighty":9.420407,"marketCap":332385447},{"date":"2020-10-09","current":2.75249,"twenty":1.651881,"median":4.578229,"eighty":9.392619,"marketCap":355221088},{"date":"2020-10-16","current":2.537281,"twenty":1.658807,"median":4.56539,"eighty":9.362569,"marketCap":327310860},{"date":"2020-10-23","current":3.004667,"twenty":1.665444,"median":4.549138,"eighty":9.317241,"marketCap":388205903},{"date":"2020-10-30","current":2.632757,"twenty":1.672076,"median":4.545601,"eighty":9.282307,"marketCap":339997327},{"date":"2020-11-06","current":2.718404,"twenty":1.683941,"median":4.537883,"eighty":9.247967,"marketCap":355221088},{"date":"2020-11-13","current":3.007111,"twenty":1.690294,"median":4.530427,"eighty":9.222351,"marketCap":393280490},{"date":"2020-11-20","current":2.891564,"twenty":1.696384,"median":4.514509,"eighty":9.207035,"marketCap":380594023},{"date":"2020-11-27","current":2.781782,"twenty":1.702668,"median":4.503584,"eighty":9.203814,"marketCap":365370262},{"date":"2020-12-04","current":2.64678,"twenty":1.707844,"median":4.491432,"eighty":9.193684,"marketCap":350146501},{"date":"2020-12-11","current":2.557096,"twenty":1.724561,"median":4.482553,"eighty":9.147292,"marketCap":337460034},{"date":"2020-12-18","current":5.102651,"twenty":1.736153,"median":4.48545,"eighty":9.115708,"marketCap":322236273},{"date":"2020-12-24","current":4.937025,"twenty":1.737666,"median":4.491432,"eighty":9.10861,"marketCap":312087099},{"date":"2020-12-31","current":5.537487,"twenty":1.740124,"median":4.502956,"eighty":9.092785,"marketCap":350146501},{"date":"2021-01-08","current":6.444668,"twenty":1.747874,"median":4.514509,"eighty":9.047388,"marketCap":411041545},{"date":"2021-01-15","current":7.208537,"twenty":1.758064,"median":4.530427,"eighty":9.019783,"marketCap":459250121},{"date":"2021-01-22","current":8.445492,"twenty":1.768009,"median":4.537043,"eighty":8.984768,"marketCap":537906219},{"date":"2021-01-29","current":7.942919,"twenty":1.76894,"median":4.542259,"eighty":8.938442,"marketCap":509995991},{"date":"2021-02-05","current":11.924246,"twenty":1.851142,"median":4.548275,"eighty":9.028537,"marketCap":761188047},{"date":"2021-02-12","current":14.445936,"twenty":1.868824,"median":4.559967,"eighty":9.120701,"marketCap":923574830},{"date":"2021-02-19","current":12.380316,"twenty":1.88933,"median":4.571167,"eighty":9.207035,"marketCap":791635568},{"date":"2021-02-26","current":8.51412,"twenty":1.913945,"median":4.592159,"eighty":9.247967,"marketCap":542980806},{"date":"2021-03-05","current":8.703275,"twenty":1.943752,"median":4.599299,"eighty":9.317241,"marketCap":553129980},{"date":"2021-03-12","current":10.400664,"twenty":1.953215,"median":4.601433,"eighty":9.361164,"marketCap":659696307},{"date":"2021-03-19","current":11.042064,"twenty":1.961921,"median":4.622901,"eighty":9.424224,"marketCap":700293003},{"date":"2021-03-26","current":9.04649,"twenty":1.96442,"median":4.63729,"eighty":9.438537,"marketCap":570891035},{"date":"2021-04-01","current":3.967248,"twenty":1.973018,"median":4.623968,"eighty":9.430511,"marketCap":579381903},{"date":"2021-04-09","current":3.769324,"twenty":1.979189,"median":4.609564,"eighty":9.424508,"marketCap":551551331},{"date":"2021-04-16","current":3.234782,"twenty":1.981324,"median":4.600302,"eighty":9.421077,"marketCap":475649772},{"date":"2021-04-23","current":3.274103,"twenty":1.983504,"median":4.594129,"eighty":9.399256,"marketCap":483239928},{"date":"2021-04-30","current":3.503774,"twenty":1.992131,"median":4.576016,"eighty":9.381766,"marketCap":518830805},{"date":"2021-05-07","current":3.345251,"twenty":1.997888,"median":4.559967,"eighty":9.365612,"marketCap":498583750},{"date":"2021-05-14","current":3.211397,"twenty":2.013914,"median":4.548275,"eighty":9.32711,"marketCap":478336694},{"date":"2021-05-21","current":3.515608,"twenty":2.035612,"median":4.542259,"eighty":9.288573,"marketCap":523892569},{"date":"2021-05-28","current":3.479656,"twenty":2.049113,"median":4.537043,"eighty":9.254986,"marketCap":523892569},{"date":"2021-06-04","current":3.679868,"twenty":2.056273,"median":4.530427,"eighty":9.23165,"marketCap":551732271},{"date":"2021-06-11","current":3.563713,"twenty":2.061219,"median":4.514509,"eighty":9.212368,"marketCap":534016097},{"date":"2021-06-18","current":2.275344,"twenty":2.061219,"median":4.502956,"eighty":9.203999,"marketCap":678276370},{"date":"2021-06-25","current":2.191357,"twenty":2.056273,"median":4.491079,"eighty":9.196938,"marketCap":652967550},{"date":"2021-07-02","current":1.87323,"twenty":2.046808,"median":4.479655,"eighty":9.160587,"marketCap":556794035},{"date":"2021-07-09","current":1.730432,"twenty":2.024506,"median":4.46865,"eighty":9.119037,"marketCap":513769041},{"date":"2021-07-16","current":1.662239,"twenty":1.98682,"median":4.463577,"eighty":9.110495,"marketCap":493521986},{"date":"2021-07-23","current":1.586083,"twenty":1.97535,"median":4.450513,"eighty":9.101009,"marketCap":470744048},{"date":"2021-07-30","current":1.53875,"twenty":1.950793,"median":4.445107,"eighty":9.084999,"marketCap":458089638},{"date":"2021-08-06","current":1.552306,"twenty":1.869705,"median":4.442504,"eighty":9.050979,"marketCap":460620520},{"date":"2021-08-13","current":1.363504,"twenty":1.777939,"median":4.417738,"eighty":9.042899,"marketCap":404941116},{"date":"2021-08-20","current":1.283065,"twenty":1.747325,"median":4.38053,"eighty":9.023933,"marketCap":379632297},{"date":"2021-08-27","current":1.300955,"twenty":1.735308,"median":4.371685,"eighty":9.001366,"marketCap":404941116},{"date":"2021-09-03","current":1.403066,"twenty":1.725747,"median":4.364162,"eighty":8.979599,"marketCap":437842582},{"date":"2021-09-10","current":1.335883,"twenty":1.705998,"median":4.3515,"eighty":8.958924,"marketCap":417595526},{"date":"2021-09-17","current":1.340381,"twenty":1.689297,"median":4.343939,"eighty":8.938442,"marketCap":417595526},{"date":"2021-09-24","current":1.23478,"twenty":1.666673,"median":4.335386,"eighty":8.908672,"marketCap":384694060},{"date":"2021-10-01","current":1.206741,"twenty":1.651695,"median":4.321627,"eighty":8.904129,"marketCap":377101415},{"date":"2021-10-08","current":1.319613,"twenty":1.642989,"median":4.309588,"eighty":8.904051,"marketCap":412533762},{"date":"2021-10-15","current":1.261176,"twenty":1.63643,"median":4.279097,"eighty":8.895162,"marketCap":394817588},{"date":"2021-10-22","current":1.475957,"twenty":1.622789,"median":4.248476,"eighty":8.878523,"marketCap":465682284},{"date":"2021-10-29","current":1.343957,"twenty":1.612811,"median":4.241881,"eighty":8.8482,"marketCap":422657290},{"date":"2021-11-05","current":1.334535,"twenty":1.602824,"median":4.216939,"eighty":8.777134,"marketCap":420126408},{"date":"2021-11-12","current":1.386525,"twenty":1.586083,"median":4.210169,"eighty":8.758487,"marketCap":437842582},{"date":"2021-11-19","current":1.219827,"twenty":1.571444,"median":4.181522,"eighty":8.71027,"marketCap":384694060},{"date":"2021-11-26","current":1.172466,"twenty":1.565489,"median":4.172071,"eighty":8.704674,"marketCap":369508769},{"date":"2021-12-03","current":0.993357,"twenty":1.547798,"median":4.150379,"eighty":8.670525,"marketCap":313829365},{"date":"2021-12-10","current":1.12025,"twenty":1.526625,"median":4.120261,"eighty":8.649487,"marketCap":354323477},{"date":"2021-12-17","current":1.090651,"twenty":1.513291,"median":4.096041,"eighty":8.570458,"marketCap":227171966},{"date":"2021-12-23","current":1.226168,"twenty":1.507688,"median":4.064994,"eighty":8.551028,"marketCap":255619079},{"date":"2021-12-31","current":1.173249,"twenty":1.493501,"median":4.041014,"eighty":8.545412,"marketCap":245267772},{"date":"2022-01-07","current":1.23969,"twenty":1.483167,"median":4.018638,"eighty":8.539701,"marketCap":258149961},{"date":"2022-01-14","current":1.283356,"twenty":1.472808,"median":3.996998,"eighty":8.523772,"marketCap":268273489},{"date":"2022-01-21","current":1.141622,"twenty":1.457851,"median":3.988936,"eighty":8.508926,"marketCap":239168347},{"date":"2022-01-28","current":1.053331,"twenty":1.44714,"median":3.979444,"eighty":8.488011,"marketCap":219908335},{"date":"2022-02-04","current":1.162555,"twenty":1.426053,"median":3.967188,"eighty":8.464405,"marketCap":242711581},{"date":"2022-02-11","current":1.199378,"twenty":1.413906,"median":3.942635,"eighty":8.453313,"marketCap":250607933},{"date":"2022-02-18","current":1.097087,"twenty":1.39743,"median":3.939304,"eighty":8.437152,"marketCap":230310260},{"date":"2022-02-25","current":1.008908,"twenty":1.387125,"median":3.918967,"eighty":8.420457,"marketCap":212087909},{"date":"2022-03-04","current":0.908009,"twenty":1.367808,"median":3.907082,"eighty":8.399056,"marketCap":190828501},{"date":"2022-03-11","current":0.869861,"twenty":1.363727,"median":3.88232,"eighty":8.372883,"marketCap":182223502},{"date":"2022-03-18","current":2.787669,"twenty":1.357838,"median":3.876736,"eighty":8.339036,"marketCap":258149961},{"date":"2022-03-25","current":3.336423,"twenty":1.35913,"median":3.866977,"eighty":8.316599,"marketCap":308767601},{"date":"2022-04-01","current":3.389728,"twenty":1.362482,"median":3.852155,"eighty":8.28079,"marketCap":313829365},{"date":"2022-04-08","current":3.444999,"twenty":1.363727,"median":3.83615,"eighty":8.259061,"marketCap":318891129},{"date":"2022-04-14","current":3.013824,"twenty":1.364618,"median":3.815106,"eighty":8.239513,"marketCap":278397017},{"date":"2022-04-22","current":2.765355,"twenty":1.365216,"median":3.792152,"eighty":8.223331,"marketCap":250557316},{"date":"2022-04-29","current":3.058969,"twenty":1.365918,"median":3.769324,"eighty":8.171844,"marketCap":272672787},{"date":"2022-05-06","current":2.828864,"twenty":1.366925,"median":3.715418,"eighty":8.148875,"marketCap":249975302},{"date":"2022-05-13","current":2.211076,"twenty":1.371339,"median":3.703028,"eighty":8.125714,"marketCap":191880850},{"date":"2022-05-20","current":2.2673,"twenty":1.379889,"median":3.673757,"eighty":8.037983,"marketCap":199556084},{"date":"2022-05-27","current":2.096332,"twenty":1.382511,"median":3.648946,"eighty":8.030691,"marketCap":184331853},{"date":"2022-06-03","current":2.359877,"twenty":1.385722,"median":3.622937,"eighty":7.960473,"marketCap":208720919},{"date":"2022-06-10","current":2.330771,"twenty":1.388925,"median":3.617264,"eighty":7.939299,"marketCap":204656075},{"date":"2022-06-17","current":-53.377821,"twenty":1.370456,"median":3.60663,"eighty":7.827996,"marketCap":254999551},{"date":"2022-06-24","current":-57.897972,"twenty":1.364977,"median":3.600751,"eighty":7.800209,"marketCap":277722283},{"date":"2022-07-01","current":-65.908222,"twenty":1.358097,"median":3.577552,"eighty":7.791874,"marketCap":315593503},{"date":"2022-07-08","current":-61.093466,"twenty":1.356202,"median":3.560157,"eighty":7.775858,"marketCap":292870771},{"date":"2022-07-15","current":-63.27086,"twenty":1.346881,"median":3.54788,"eighty":7.722016,"marketCap":300445015},{"date":"2022-07-22","current":-61.624682,"twenty":1.339656,"median":3.542243,"eighty":7.650027,"marketCap":292870771},{"date":"2022-07-29","current":-59.967811,"twenty":1.335074,"median":3.524398,"eighty":7.62701,"marketCap":285296527},{"date":"2022-08-05","current":-59.057527,"twenty":1.329074,"median":3.509691,"eighty":7.610735,"marketCap":280247031},{"date":"2022-08-12","current":-57.299923,"twenty":1.30399,"median":3.480521,"eighty":7.56646,"marketCap":272672787},{"date":"2022-08-19","current":-57.399968,"twenty":1.294829,"median":3.474363,"eighty":7.529188,"marketCap":270148039},{"date":"2022-08-26","current":-55.693437,"twenty":1.28847,"median":3.451858,"eighty":7.459046,"marketCap":260049047},{"date":"2022-09-02","current":-50.865077,"twenty":1.282236,"median":3.439352,"eighty":7.329916,"marketCap":236543642},{"date":"2022-09-09","current":-4.427371,"twenty":1.27284,"median":3.41825,"eighty":7.262178,"marketCap":232276818},{"date":"2022-09-16","current":-4.711862,"twenty":1.26766,"median":3.389728,"eighty":7.055763,"marketCap":244900558},{"date":"2022-09-23","current":-4.507036,"twenty":1.255102,"median":3.334228,"eighty":6.430231,"marketCap":229752070},{"date":"2022-09-30","current":-4.449063,"twenty":1.241844,"median":3.305952,"eighty":6.36321,"marketCap":227227322},{"date":"2022-10-07","current":-4.649044,"twenty":1.233685,"median":3.272439,"eighty":6.315153,"marketCap":237427304},{"date":"2022-10-14","current":-4.397095,"twenty":1.224175,"median":3.258319,"eighty":6.268831,"marketCap":222177826},{"date":"2022-10-21","current":-4.517358,"twenty":1.21703,"median":3.258055,"eighty":6.263868,"marketCap":226697125},{"date":"2022-10-28","current":-4.17876,"twenty":1.21703,"median":3.258055,"eighty":6.263868,"marketCap":209352106},{"date":"2022-11-04","current":-4.316899,"twenty":1.21703,"median":3.258055,"eighty":6.263868,"marketCap":218365457},{"date":"2022-11-11","current":-4.435179,"twenty":1.21703,"median":3.258055,"eighty":6.263868,"marketCap":226747620},{"date":"2022-11-18","current":-4.188263,"twenty":1.206309,"median":3.214152,"eighty":6.038554,"marketCap":213745168},{"date":"2022-11-25","current":-1.441004,"twenty":1.196321,"median":3.183506,"eighty":5.919731,"marketCap":184306606},{"date":"2022-12-02","current":-1.739144,"twenty":1.190341,"median":3.139792,"eighty":5.695609,"marketCap":227227322},{"date":"2022-12-09","current":-1.627951,"twenty":1.184355,"median":3.058969,"eighty":5.613624,"marketCap":214628830},{"date":"2022-12-16","current":-1.787897,"twenty":1.173368,"median":3.004667,"eighty":5.573461,"marketCap":235205526},{"date":"2022-12-23","current":-1.845396,"twenty":1.166568,"median":2.973405,"eighty":5.526558,"marketCap":242224325},{"date":"2022-12-30","current":-1.809474,"twenty":1.152461,"median":2.926816,"eighty":5.501262,"marketCap":240608487},{"date":"2023-01-06","current":-2.145642,"twenty":1.147922,"median":2.899588,"eighty":5.479696,"marketCap":287821275},{"date":"2023-01-13","current":-2.06881,"twenty":1.140337,"median":2.875567,"eighty":5.427519,"marketCap":282771779},{"date":"2023-01-20","current":-2.016512,"twenty":1.137891,"median":2.86131,"eighty":5.392337,"marketCap":272672787},{"date":"2023-01-27","current":-2.259537,"twenty":1.116984,"median":2.824171,"eighty":5.370803,"marketCap":305494511},{"date":"2023-02-03","current":-2.34562,"twenty":1.101853,"median":2.781782,"eighty":5.34608,"marketCap":318118251},{"date":"2023-02-10","current":-2.473528,"twenty":1.090277,"median":2.763282,"eighty":5.316369,"marketCap":333266739},{"date":"2023-02-17","current":-2.533318,"twenty":1.079518,"median":2.732178,"eighty":5.287677,"marketCap":338316236},{"date":"2023-02-24","current":-5.725247,"twenty":1.056339,"median":2.690651,"eighty":5.254644,"marketCap":297920267},{"date":"2023-03-03","current":-5.828855,"twenty":1.037848,"median":2.654874,"eighty":5.22864,"marketCap":305494511},{"date":"2023-03-10","current":-5.456639,"twenty":1.023348,"median":2.647052,"eighty":5.204033,"marketCap":285296527},{"date":"2023-03-17","current":-5.667715,"twenty":1.001884,"median":2.632757,"eighty":5.155718,"marketCap":297920267},{"date":"2023-03-24","current":-5.748207,"twenty":0.988622,"median":2.592496,"eighty":5.123544,"marketCap":302969763},{"date":"2023-03-31","current":-5.74963,"twenty":0.981636,"median":2.560383,"eighty":5.106116,"marketCap":302969763},{"date":"2023-04-06","current":-5.611278,"twenty":0.961891,"median":2.541113,"eighty":5.097377,"marketCap":295395519},{"date":"2023-04-14","current":-5.65364,"twenty":0.948412,"median":2.488418,"eighty":5.048439,"marketCap":297920267},{"date":"2023-04-21","current":-6.231763,"twenty":0.935717,"median":2.439054,"eighty":5.022245,"marketCap":328217243},{"date":"2023-04-28","current":-5.892181,"twenty":0.913999,"median":2.35477,"eighty":4.997161,"marketCap":308019259},{"date":"2023-05-05","current":-5.53935,"twenty":0.906432,"median":2.330771,"eighty":4.985267,"marketCap":290119614},{"date":"2023-05-12","current":-5.396481,"twenty":0.890665,"median":2.309302,"eighty":4.971094,"marketCap":281123657},{"date":"2023-05-19","current":-5.468089,"twenty":0.873834,"median":2.26799,"eighty":4.953015,"marketCap":281123657},{"date":"2023-05-26","current":-5.890594,"twenty":0.84026,"median":2.223866,"eighty":4.941783,"marketCap":301364560},{"date":"2023-06-02","current":-6.08478,"twenty":0.822461,"median":2.20614,"eighty":4.930121,"marketCap":310360517},{"date":"2023-06-09","current":-7.997073,"twenty":0.753762,"median":2.191357,"eighty":4.862414,"marketCap":407067056},{"date":"2023-06-16","current":14.961744,"twenty":0.730045,"median":2.189117,"eighty":4.854051,"marketCap":409316045},{"date":"2023-06-23","current":16.549358,"twenty":0.725764,"median":2.188964,"eighty":4.847095,"marketCap":449797852},{"date":"2023-06-30","current":16.548854,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":445299873},{"date":"2023-07-07","current":16.798434,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":452046841},{"date":"2023-07-14","current":18.049358,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":492528647},{"date":"2023-07-21","current":17.617452,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":479034712},{"date":"2023-07-28","current":18.520305,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":503773594},{"date":"2023-08-04","current":19.822164,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":539757422},{"date":"2023-08-11","current":20.546635,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":555500347},{"date":"2023-08-18","current":18.151135,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":485781680},{"date":"2023-08-25","current":19.54183,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":524014497},{"date":"2023-09-01","current":21.080767,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":566745293},{"date":"2023-09-08","current":17.988448,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":440801894},{"date":"2023-09-15","current":18.317701,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":452046841},{"date":"2023-09-22","current":18.211445,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":447548862},{"date":"2023-09-29","current":19.475841,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":479034712},{"date":"2023-10-06","current":18.743843,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":461042798},{"date":"2023-10-13","current":18.65139,"twenty":0.721483,"median":2.188811,"eighty":4.867143,"marketCap":458793809},{"date":"2023-10-20","current":17.497268,"twenty":0.721483,"median":2.188811,"eighty":4.934175,"marketCap":429556948},{"date":"2023-10-27","current":16.217847,"twenty":-0.124554,"median":2.185731,"eighty":4.941783,"marketCap":398071099},{"date":"2023-11-03","current":15.850472,"twenty":-0.124554,"median":2.185731,"eighty":4.959403,"marketCap":389075141},{"date":"2023-11-10","current":15.688202,"twenty":-0.124554,"median":2.185731,"eighty":4.984734,"marketCap":386826152},{"date":"2023-11-17","current":15.779975,"twenty":-0.124554,"median":2.185731,"eighty":5.009021,"marketCap":391324131},{"date":"2023-11-24","current":14.407243,"twenty":-0.124554,"median":2.185731,"eighty":5.031648,"marketCap":362087270},{"date":"2023-12-01","current":14.119989,"twenty":-0.124554,"median":2.185731,"eighty":5.061029,"marketCap":355340303},{"date":"2023-12-08","current":16.375706,"twenty":0.296324,"median":2.187935,"eighty":5.102649,"marketCap":411565034},{"date":"2023-12-15","current":5.13977,"twenty":0.296324,"median":2.187935,"eighty":5.09701,"marketCap":467789766},{"date":"2023-12-22","current":5.193137,"twenty":0.296324,"median":2.187935,"eighty":5.09701,"marketCap":470038755},{"date":"2023-12-29","current":5.167392,"twenty":-0.124554,"median":2.185731,"eighty":5.105888,"marketCap":470038755},{"date":"2024-01-05","current":5.271514,"twenty":-0.545433,"median":2.183526,"eighty":5.117907,"marketCap":476785723},{"date":"2024-01-12","current":5.442904,"twenty":-0.545433,"median":2.183526,"eighty":5.148286,"marketCap":492528647},{"date":"2024-01-19","current":5.433825,"twenty":-0.966311,"median":2.182901,"eighty":5.16623,"marketCap":488030669},{"date":"2024-01-26","current":5.069182,"twenty":-0.545433,"median":2.183526,"eighty":5.152858,"marketCap":458793809},{"date":"2024-02-02","current":5.346932,"twenty":-0.545433,"median":2.183526,"eighty":5.165068,"marketCap":481283701},{"date":"2024-02-09","current":5.478707,"twenty":-0.545433,"median":2.183526,"eighty":5.198595,"marketCap":494777637},{"date":"2024-02-16","current":6.309669,"twenty":-0.545433,"median":2.183526,"eighty":5.238229,"marketCap":568994282},{"date":"2024-02-23","current":6.132491,"twenty":-0.545433,"median":2.183526,"eighty":5.278851,"marketCap":551002368},{"date":"2024-03-01","current":6.129507,"twenty":-0.124554,"median":2.185731,"eighty":5.28407,"marketCap":551002368},{"date":"2024-03-08","current":5.831557,"twenty":-0.124554,"median":2.185731,"eighty":5.293518,"marketCap":524014497},{"date":"2024-03-15","current":6.107883,"twenty":-0.124554,"median":2.185731,"eighty":5.315877,"marketCap":548753379},{"date":"2024-03-22","current":103.435233,"twenty":-0.124554,"median":2.185731,"eighty":5.348813,"marketCap":562247315},{"date":"2024-03-28","current":103.41931,"twenty":-0.124554,"median":2.185731,"eighty":5.36835,"marketCap":559998325},{"date":"2024-04-05","current":99.779196,"twenty":-0.545433,"median":2.183526,"eighty":5.384537,"marketCap":539757422},{"date":"2024-04-12","current":101.071124,"twenty":-0.545433,"median":2.183526,"eighty":5.402533,"marketCap":546504390},{"date":"2024-04-19","current":93.598599,"twenty":-0.545433,"median":2.183526,"eighty":5.433865,"marketCap":506022583},{"date":"2024-04-26","current":101.175863,"twenty":-0.124554,"median":2.185731,"eighty":5.454663,"marketCap":546504390},{"date":"2024-05-03","current":100.260037,"twenty":-0.124554,"median":2.185731,"eighty":5.479265,"marketCap":542006411},{"date":"2024-05-10","current":79.679719,"twenty":-0.124554,"median":2.185731,"eighty":5.479265,"marketCap":431840780},{"date":"2024-05-17","current":68.485221,"twenty":-0.124554,"median":2.185731,"eighty":5.504513,"marketCap":371231547},{"date":"2024-05-24","current":60.287412,"twenty":-0.124554,"median":2.185731,"eighty":5.616715,"marketCap":325774623},{"date":"2024-05-31","current":59.936079,"twenty":-0.124554,"median":2.185731,"eighty":5.781947,"marketCap":323880585},{"date":"2024-06-07","current":57.857018,"twenty":-0.124554,"median":2.185731,"eighty":5.86056,"marketCap":312516354},{"date":"2024-06-14","current":-5.111058,"twenty":-1.39972,"median":2.182277,"eighty":5.972137,"marketCap":316304431},{"date":"2024-06-21","current":-5.791635,"twenty":-1.513498,"median":2.164796,"eighty":5.975765,"marketCap":357973278},{"date":"2024-06-28","current":-5.736583,"twenty":-1.56144,"median":2.157614,"eighty":5.995678,"marketCap":354185201},{"date":"2024-07-05","current":-5.737924,"twenty":-1.647893,"median":2.11897,"eighty":5.995678,"marketCap":354185201},{"date":"2024-07-12","current":-5.544422,"twenty":-1.785668,"median":2.096332,"eighty":5.995678,"marketCap":342820970},{"date":"2024-07-15","current":-5.480589,"twenty":-1.788185,"median":2.092657,"eighty":5.995678,"marketCap":339032893},{"date":"2024-08-02","current":-5.440877,"twenty":-1.799974,"median":2.061277,"eighty":6.054033,"marketCap":337138854},{"date":"2024-08-09","current":-5.117277,"twenty":-1.845396,"median":2.034008,"eighty":6.054033,"marketCap":320092508},{"date":"2024-08-16","current":-5.450277,"twenty":-1.902036,"median":1.990803,"eighty":6.054033,"marketCap":340926931},{"date":"2024-08-23","current":-5.548409,"twenty":-2.06444,"median":1.969537,"eighty":6.054033,"marketCap":348503085},{"date":"2024-08-30","current":-5.422274,"twenty":-2.132648,"median":1.906636,"eighty":6.054033,"marketCap":342820970},{"date":"2024-09-06","current":-5.507717,"twenty":-2.192208,"median":1.858821,"eighty":6.054033,"marketCap":348503085},{"date":"2024-09-13","current":-9.164942,"twenty":-2.305525,"median":1.754206,"eighty":6.054033,"marketCap":350397124},{"date":"2024-09-20","current":-9.248138,"twenty":-2.4266,"median":1.735942,"eighty":6.054033,"marketCap":356079239},{"date":"2024-09-27","current":-9.857249,"twenty":-2.554208,"median":1.725079,"eighty":6.054033,"marketCap":382595779},{"date":"2024-10-04","current":-10.767472,"twenty":-4.167739,"median":1.694449,"eighty":6.054033,"marketCap":416688472},{"date":"2024-10-11","current":-10.349658,"twenty":-4.226527,"median":1.67005,"eighty":6.054033,"marketCap":397748087},{"date":"2024-10-18","current":-10.261164,"twenty":-4.307673,"median":1.65115,"eighty":6.054033,"marketCap":392065971},{"date":"2024-10-25","current":-11.347424,"twenty":-4.342601,"median":1.641046,"eighty":6.054033,"marketCap":433734818},{"date":"2024-10-31","current":-11.642279,"twenty":-4.424771,"median":1.629603,"eighty":6.054033,"marketCap":445099049},{"date":"2024-11-08","current":-11.890684,"twenty":-4.437526,"median":1.614876,"eighty":6.064803,"marketCap":452675203},{"date":"2024-11-15","current":-11.580432,"twenty":-4.453178,"median":1.602824,"eighty":6.064803,"marketCap":435628857},{"date":"2024-11-22","current":-12.242757,"twenty":-4.500185,"median":1.585373,"eighty":6.064803,"marketCap":460251357},{"date":"2024-11-29","current":105.02825,"twenty":-4.500185,"median":1.585373,"eighty":6.132491,"marketCap":594728092},{"date":"2024-12-06","current":101.226386,"twenty":-4.500185,"median":1.585373,"eighty":6.322232,"marketCap":571999630},{"date":"2024-12-13","current":98.989053,"twenty":-4.500185,"median":1.585373,"eighty":7.397105,"marketCap":558741360},{"date":"2024-12-20","current":85.236807,"twenty":-4.500185,"median":1.585373,"eighty":8.248611,"marketCap":479191743},{"date":"2024-12-27","current":98.062015,"twenty":-4.500185,"median":1.585373,"eighty":8.459218,"marketCap":551165206},{"date":"2025-01-03","current":94.372016,"twenty":-4.500185,"median":1.585373,"eighty":8.718047,"marketCap":530330782},{"date":"2025-01-10","current":92.424911,"twenty":-4.501898,"median":1.584133,"eighty":8.928773,"marketCap":517072513},{"date":"2025-01-17","current":91.747806,"twenty":-4.501898,"median":1.584488,"eighty":9.39695,"marketCap":513284436},{"date":"2025-01-24","current":98.596639,"twenty":-4.501898,"median":1.601225,"eighty":9.783586,"marketCap":554953283},{"date":"2025-01-31","current":99.438002,"twenty":-4.501898,"median":1.613843,"eighty":10.562535,"marketCap":562529437},{"date":"2025-02-07","current":99.950895,"twenty":-4.501898,"median":1.625636,"eighty":11.383302,"marketCap":562529437},{"date":"2025-02-14","current":100.350725,"twenty":-4.501898,"median":1.641046,"eighty":12.297388,"marketCap":564423475},{"date":"2025-02-21","current":107.205077,"twenty":-4.501898,"median":1.647915,"eighty":12.677797,"marketCap":606092323},{"date":"2025-02-28","current":94.118612,"twenty":-4.501898,"median":1.664456,"eighty":14.155737,"marketCap":530330782},{"date":"2025-03-07","current":91.684274,"twenty":-4.50361,"median":1.691225,"eighty":14.495249,"marketCap":518966551},{"date":"2025-03-14","current":90.651653,"twenty":-4.50361,"median":1.724908,"eighty":15.427996,"marketCap":513284436},{"date":"2025-03-21","current":96.715498,"twenty":-4.50361,"median":1.734885,"eighty":15.679813,"marketCap":547377129},{"date":"2025-03-28","current":89.912948,"twenty":-4.50361,"median":1.752834,"eighty":15.814795,"marketCap":507602320},{"date":"2025-04-04","current":88.086277,"twenty":-4.50361,"median":1.851142,"eighty":15.971694,"marketCap":496238089},{"date":"2025-04-11","current":77.337205,"twenty":-4.501898,"median":1.906636,"eighty":16.218055,"marketCap":433734818},{"date":"2025-04-17","current":82.909148,"twenty":-4.501898,"median":1.979101,"eighty":16.305595,"marketCap":465933473}],"updateTime":1745262370127}}}